Ars Pharmaceuticals Inc (SPRY)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
4. 02
-0.05
-1.2285%
$
420.05M Market Cap
- P/E Ratio
- Div Yield
2.33M Volume
-0.61 Eps
$ 4.07
Previous Close 
Want to track SPRY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ars Pharmaceuticals Inc (SPRY) Statistics
Valuation metrics
Market Cap 420.05M
Enterprise value 583.49M
Trailing P/E (ttm) -1.94
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 3.59
Price/Book (mrq) 33.58
Enterprise Value/Revenue 4.99
Enterprise Value/EBITDA -2.82
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.28M
Average volume (90 days) 2.29M
Price summary
52-Week low 3.81
52-Week high 13.15
Beta -
50-Day moving average 4.27
200-Day moving average 7.7
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.84%
Operating margin -1.85%
Operational effectiveness
Return on assets -0.86%
Return on equity -2.57%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.18
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.17
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.45
Total debt (mrq) -
Total Debt/Equity (mrq) 13.72
Current ratio (mrq) 3.48%
Book value per share (mrq) 0.13
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
